Moderna Says Vaccine Efficacy Data Could Come by Thanksgiving
This article is for subscribers only.
Moderna Inc. Chief Executive Officer Stephane Bancel said efficacy data for its Covid-19 vaccine could be available by as soon as Thanksgiving if everything goes right.
Moderna’s coronavirus vaccine is in second-stage trials, with final-stage trials set to begin next month on 30,000 people. In an interview on Bloomberg Television on Monday with David Rubenstein, Bancel said in a best-case scenario “we could have efficacy data by Thanksgiving. This is the best time line.”